Submission Details
| 510(k) Number | K243070 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2024 |
| Decision Date | October 25, 2024 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K243070 is an FDA 510(k) clearance for the Xpert? SA Nasal Complete, a System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen (Class II — Special Controls, product code NQX), submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on October 25, 2024, 28 days after receiving the submission on September 27, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K243070 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2024 |
| Decision Date | October 25, 2024 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NQX — System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |
| Definition | A Nucleic Acid Amplification Assay System (including Probes, Other Reagents, And Instrumentation) Is An Aid In The Identification Of Mrsa Colonization Status For The Prevention And Control Of Mrsa Infections In Healthcare Settings. |